MDWERKS INC (MDWK) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MDWK SEC filings page.
MDWERKS INC (MDWK) reported $2.2M in revenue over the twelve months to Jun 30, 2026, down 4.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Growth in scale has not stabilized the model: gross-profit reversal, operating-cost intensity, and financing dependence now dominate MDwerks.
Revenue reached$2.2M by FY2025, while gross margin swung to-15.8% from positive territory in FY2023; scale did not preserve unit economics. Operating cash flow was-$1.6M while free cash flow was-$2.4M , showing that the gap extends beyond reported earnings into ongoing investment needs.
The cost structure outgrew the sales base: SG&A reached
Financing cash inflow of
Financial Health Signals
MDWERKS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
MDWERKS INC scores -1.33, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($18.6M) relative to total liabilities ($3.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
MDWERKS INC passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
MDWERKS INC reported a net loss of $3.8M while operations used $1.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
MDWERKS INC reported an operating loss of $3.7M against $62K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
MDWERKS INC generated $524K in revenue in Q2 2026. This represents an increase of 24.6% from the same quarter a year earlier. Against the prior quarter it is up 20.7%.
MDWERKS INC's EBITDA was -$416K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 66.6% from the same quarter a year earlier. Against the prior quarter it is up 46.0%.
MDWERKS INC reported -$530K in net income in Q2 2026. This represents an increase of 60.4% from the same quarter a year earlier. Against the prior quarter it is up 37.4%.
MDWERKS INC earned $0.00 per diluted share (EPS) in Q2 2026. This represents an increase of 100.0% from the same quarter a year earlier.
Cash & Balance Sheet
MDWERKS INC recorded an outflow of $166K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 67.6% from the same quarter a year earlier. Against the prior quarter it is up 68.5%.
MDWERKS INC held $13K in cash against $541K in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
MDWERKS INC's gross margin was 13.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 80.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 45.2 percentage points.
MDWERKS INC's operating margin was -97.2% in Q2 2026, reflecting core business profitability. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
MDWERKS INC's ROE was -198.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 65.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 67.8 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
MDWERKS INC invested $25K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 76.2% from the same quarter a year earlier. Against the prior quarter it is down 60.9%.
Not reported for Q2 2026.
Not reported for Q2 2026.
MDWK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $524K+24.6% | $434K-15.5% | $500K+43.3% | $780K-26.3% | $421K+54.7% | $514K-24.9% | $349K | $1.1M |
| Cost of Revenue | $452K-35.7% | $570K+49.5% | $820K+90.2% | $662K+103.1% | $702K+104.4% | $381K-2.2% | $431K | $326K |
| Gross Profit | $72K+125.7% | -$136K-202.8% | -$320K-289.3% | $118K-83.9% | -$281K-293.3% | $133K-55.0% | -$82K | $733K |
| SG&A Expenses | $324K-45.1% | $488K-16.4% | $203K-35.5% | $926K+87.2% | $589K+9.4% | $584K+15.4% | $314K | $495K+285.1% |
| Operating Income | -$510K+61.5% | -$838K-35.6% | -$802K-21.7% | -$992K-709.0% | -$1.3M-88.8% | -$618K-102.5% | -$659K | $163K+226.2% |
| EBITDA | -$416K+66.6% | -$770K-41.3% | -$718K-23.5% | -$907K-508.9% | -$1.2M-98.9% | -$545K-139.9% | -$581K | $222K+272.7% |
| Interest Expense | $20K+63.7% | $9K-21.6% | $11K+91.1% | $26K+235.5% | $12K+83.2% | $12K+314.0% | $6K | $8K+84.5% |
| Net Income | -$530K+60.4% | -$847K-34.6% | -$813K-14.3% | -$1.0M-748.6% | -$1.3M-75.0% | -$629K-108.1% | -$712K | $157K+342.4% |
| EPS (Basic) | $0.00+100.0% | $0.00 | -$0.010.0% | -$0.01 | -$0.01 | $0.00 | -$0.01 | $0.00 |
| EPS (Diluted) | $0.00+100.0% | $0.00 | -$0.010.0% | -$0.01 | -$0.01 | $0.00 | -$0.01 | $0.00 |
| Diluted Shares (Avg) | 238M+7.8% | 235M+11.8% | N/A | 223M+11.0% | 220M+9.7% | 211M+5.8% | N/A | 201M+60.0% |
Not reported in any period shown, so not listed: R&D Expenses, Income Tax.
MDWK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.9M-11.6% | $4.2M-16.2% | $4.0M+38.8% | $4.4M+49.8% | $4.4M+51.0% | $5.0M+70.6% | $2.9M-9.8% | $2.9M+599.8% |
| Current Assets | $836K-38.7% | $965K-50.8% | $1.2M+211.9% | $1.4M+146.5% | $1.4M+267.1% | $2.0M+196.4% | $374K-31.9% | $580K+140.5% |
| Cash & Equivalents | $13K-0.5% | $96K-83.9% | $212K+1799.3% | $181K+190.1% | $13K-72.0% | $593K+264.1% | $11K-90.3% | $62K-62.4% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $585K-50.1% | $680K-38.5% | $821K+246.6% | $1.0M+442.9% | $1.2M+670.8% | $1.1M+588.6% | $237K+17.7% | $189K |
| Accounts Receivable | $97K+49.5% | $25K-73.8% | $43K-60.2% | $118K-43.6% | $65K+18.4% | $95K-53.8% | $109K+2.3% | $209K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $467K0.0% | $467K0.0% | $467K0.0% | $467K0.0% | $467K0.0% | $467K0.0% | $467K0.0% | $467K |
| Total Liabilities | $3.6M+6.8% | $3.5M+28.8% | $3.0M+19.7% | $3.2M+33.8% | $3.4M+29.6% | $2.7M+65.3% | $2.5M+22.8% | $2.4M+1036.9% |
| Current Liabilities | $2.9M+18.2% | $2.7M+57.9% | $2.4M+49.6% | $2.4M+75.2% | $2.5M+58.9% | $1.7M+50.7% | $1.6M+51.7% | $1.3M |
| Non-Current Liabilities | $705K-23.8% | $773K-22.2% | $624K-32.6% | $845K-19.3% | $925K-13.2% | $994K+99.2% | $927K-7.9% | $1.0M |
| Long-Term Debt | $541K-1.9% | $477K-30.3% | $368K-24.8% | $463K-12.0% | $552K-1.2% | $684K+20.1% | $489K+158.4% | $526K |
| Total Equity | $267K-73.5% | $650K-71.0% | $1.0M+170.1% | $1.2M+29.5% | $1.0M+102.5% | $2.2M+77.5% | $371K-68.0% | $906K+338.4% |
| Retained Earnings | -$7.5M-74.2% | -$7.0M-134.3% | -$6.2M-160.9% | -$5.3M-224.2% | -$4.3M-139.6% | -$3.0M-187.0% | -$2.4M-219.3% | -$1.6M-215.0% |
MDWK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$141K+65.5% | -$464K-10.2% | -$380K-218.5% | -$363K-77.6% | -$410K-131.0% | -$421K-50.0% | -$119K+52.9% | -$204K-58.7% |
| Depreciation & Amortization | $93K+18.7% | $68K-6.9% | $84K+8.1% | $85K+43.8% | $79K+4.6% | $73K-6.8% | $78K+435.3% | $59K+9171.9% |
| Stock-Based Compensation | N/A | $45K-32.3% | N/A | N/A | N/A | $66K+342.1% | N/A | N/A |
| Capital Expenditures | -$25K-76.2% | $63K-89.6% | $94K | $71K+3759.5% | $103K | $604K+6752.3% | $0 | -$2K |
| Free Cash Flow | -$166K+67.6% | -$527K+48.6% | -$474K-297.5% | -$434K-110.3% | -$513K-189.1% | -$1.0M-254.0% | -$119K+52.9% | -$206K-60.1% |
| Investing Cash Flow | $25K+123.8% | -$63K+89.6% | -$94K | -$71K-3959.5% | -$103K | -$604K-6752.3% | $0-100.0% | $2K-92.7% |
| Financing Cash Flow | $34K+151.4% | $411K-74.4% | $505K+642.8% | $602K+176.8% | -$67K-207.7% | $1.6M+376.3% | $68K-15.6% | $217K-17.9% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
MDWK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.8%+80.7pp | -31.4%-57.2pp | -64.0%-40.4pp | 15.2%-54.1pp | -66.9%-40.6pp | 25.8%-17.3pp | -23.5% | 69.2% |
| Operating Margin | -97.2% | -193.0% | -160.4% | -127.2% | -314.9% | -120.2% | -188.9% | 15.4% |
| Net Margin | -101.1% | -195.1% | -162.7% | -130.6% | -317.9% | -122.5% | -204.0% | 14.8% |
| Return on Equity | -198.1%-65.7pp | -130.3%-102.2pp | -81.1%+110.7pp | -86.9%-104.2pp | -132.4%+20.8pp | -28.1%-4.1pp | -191.8% | 17.3%+0.2pp |
| Return on Assets | -13.6%+16.7pp | -20.3%-7.7pp | -20.1%+4.3pp | -23.3%-28.7pp | -30.4%-4.2pp | -12.7%-2.3pp | -24.4% | 5.4%-3.1pp |
| Current Ratio | 0.29-0.3x | 0.35-0.8x | 0.48+0.3x | 0.61+0.2x | 0.55+0.3x | 1.13+0.6x | 0.23-0.3x | 0.43 |
| Debt-to-Equity | 2.02+1.5x | 0.73+0.4x | 0.37-1.0x | 0.39-0.2x | 0.55-0.6x | 0.30-0.1x | 1.32+1.2x | 0.58-0.4x |
| Asset Turnover | 0.130.0x | 0.100.0x | 0.120.0x | 0.18-0.2x | 0.100.0x | 0.10-0.1x | 0.12 | 0.36 |
| FCF Margin | -31.7% | -121.5% | -94.8%-60.7pp | -55.6%-36.1pp | -122.0% | -199.6% | -34.2% | -19.5% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.48), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| MDWERKS INC MDWK | FY2025 | $2.2M | -$3.8M | N/A | $18.6M | — |
| INCEPTION GROWTH ACQ LTD IGTA | FY2025 | N/A | -$1.0M | N/A | $44.8M | — |
| WELSBACH TECH METALS ACQ WTMA | FY2025 | N/A | -$1.8M | N/A | $39.1M | — |
| MOUNTAIN CREST ACQ V MCAG | FY2025 | N/A | -$431K | N/A | $37.1M | — |
Where MDWERKS INC Ranks
Frequently Asked Questions
What is MDWERKS INC's annual revenue?
MDWERKS INC (MDWK) reported $2.2M in total revenue for fiscal year 2025. This represents a -6.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is MDWERKS INC's revenue growing?
MDWERKS INC (MDWK) revenue declined by 6.3% year-over-year, from $2.4M to $2.2M in fiscal year 2025.
Is MDWERKS INC profitable?
No, MDWERKS INC (MDWK) reported a net income of -$3.8M in fiscal year 2025.
What is MDWERKS INC's EBITDA?
MDWERKS INC (MDWK) had EBITDA of -$3.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does MDWERKS INC have?
As of fiscal year 2025, MDWERKS INC (MDWK) had $212K in cash and equivalents against $368K in long-term debt.
What is MDWERKS INC's gross margin?
MDWERKS INC (MDWK) had a gross margin of -15.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is MDWERKS INC's return on equity (ROE)?
MDWERKS INC (MDWK) has a return on equity of -378.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is MDWERKS INC's free cash flow?
MDWERKS INC (MDWK) recorded an outflow of $2.4M in free cash flow during fiscal year 2025. This represents a -210.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is MDWERKS INC's operating cash flow?
MDWERKS INC (MDWK) recorded an outflow of $1.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are MDWERKS INC's total assets?
MDWERKS INC (MDWK) had $4.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are MDWERKS INC's capital expenditures?
MDWERKS INC (MDWK) invested $872K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is MDWERKS INC's current ratio?
MDWERKS INC (MDWK) had a current ratio of 0.48 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is MDWERKS INC's debt-to-equity ratio?
MDWERKS INC (MDWK) had a debt-to-equity ratio of 0.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is MDWERKS INC's return on assets (ROA)?
MDWERKS INC (MDWK) had a return on assets of -93.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is MDWERKS INC's P/E ratio?
MDWERKS INC (MDWK) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $18.6M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is MDWERKS INC's price-to-sales ratio?
MDWERKS INC (MDWK) trades at 8.3x sales, its market capitalization divided by revenue of $2.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $18.6M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does MDWERKS INC's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, MDWERKS INC (MDWK) held $212K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.6M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is MDWERKS INC's Altman Z-Score?
MDWERKS INC (MDWK) has an Altman Z-Score of -1.33, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is MDWERKS INC's Piotroski F-Score?
MDWERKS INC (MDWK) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are MDWERKS INC's earnings high quality?
MDWERKS INC (MDWK) reported a net loss of $3.8M while operations used $1.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can MDWERKS INC cover its interest payments?
MDWERKS INC (MDWK) reported an operating loss of $3.7M against $62K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.